[1]郭 磊,王小文,向小勇.中性粒细胞与淋巴细胞比值与肺癌预后关系研究[J].医学信息,2019,32(09):35-37,44.[doi:10.3969/j.issn.1006-1959.2019.09.012]
 GUO Lei,WANG Xiao-wen,XIANG Xiao-yong.Relationship between Neutrophil-lymphocyte Ratio and Prognosis of Lung Cancer[J].Journal of Medical Information,2019,32(09):35-37,44.[doi:10.3969/j.issn.1006-1959.2019.09.012]
点击复制

中性粒细胞与淋巴细胞比值与肺癌预后关系研究()
分享到:

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
32卷
期数:
2019年09期
页码:
35-37,44
栏目:
综述
出版日期:
2019-05-01

文章信息/Info

Title:
Relationship between Neutrophil-lymphocyte Ratio and Prognosis of Lung Cancer
文章编号:
1006-1959(2019)09-0035-04
作者:
郭 磊王小文向小勇
(重庆医科大学附属第一医院胸心外科,重庆 400000)
Author(s):
GUO LeiWANG Xiao-wenXIANG Xiao-yong
(Department of Thoracic and Cardiovascular Surgery,the First Affiliated Hospital of Chongqing Medical University,Chongqing 400000,China)
关键词:
中性粒细胞与淋巴细胞比值炎性反应肺癌预后
Keywords:
Neutrophil to lymphocyte ratioInflammatory responseLung cancerPrognosis
分类号:
R734.2
DOI:
10.3969/j.issn.1006-1959.2019.09.012
文献标志码:
A
摘要:
肺癌是我国发病率最高、死亡率最高的恶性肿瘤。研究表明,机体炎性指标如中性粒细胞与淋巴细胞比值(NLR),在评估恶性肿瘤的发展以及预测恶性肿瘤的预后有一定意义,且NLR在临床工作中较易获得数据,具有较高的经济效率和临床参考价值。本文将根据近年来国内外有关NLR与肺癌预后的关系的文献进行总结,综述NLR在肺癌预后中应用。
Abstract:
Lung cancer is the most common malignant tumor in China with the highest incidence and mortality. Studies have shown that the body's inflammatory index, such as neutrophil to lymphocyte ratio (NLR), has a certain significance in assessing the development of malignant tumors and predicting the prognosis of malignant tumors, and NLR is easier to obtain data in clinical work, with higher Economic efficiency and clinical reference value. This article will summarize the literature on the relationship between NLR and lung cancer prognosis in recent years, and review the application of NLR in the prognosis of lung cancer.

参考文献/References:

[1]Bray F,Ferlay J,Soerjomataram I,et al.Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries[J].CA-A Cancer Journal For Clinicians,2018,68(6):394-424.
[2]陈万青,孙可欣,郑荣寿,等.2014年中国分地区恶性肿瘤发病和死亡分析[J].中国肿瘤,2018,27(1):1-14.
[3]Ben-Neriah Y,Lasrey A,Aran D,et al.A variety of cancer-associated inflammatory reactions[A]//Special Issue:41st FEBS Congress, Molecular and Systems Biology for a Better Life[C].Ephesus,Turkey:FEBS Journal,2016.
[4]高肇妤,梁迪,靳晶,等.中性粒细胞在肺癌发展及预后中的作用[J].肿瘤,2017,37(8):889-894.
[5]周昳欣,郝吉庆.外周血中性粒细胞与淋巴细胞比值评估小细胞肺癌患者预后的价值[J].中华疾病控制杂志,2017,21(8):827-834.
[6]王洪玲,李琳,王键玮,等.中性粒细胞淋巴细胞比值与非小细胞肺癌预后关系的分析[J].河北医科大学学报,2018,39(4):391-395.
[7]Suzuki R,Wei X,Pamela KA,et al.Prognostic Significance of Total Lymphocyte Count, Neutrophil-to-lymphocyte Ratio,and Platelet-to-lymphocyte Ratio in Limited-stage Small-cell Lung Cancer[J].Clinical Lung Cancer,2019,20(2):117-123.
[8]Suzuki R,Steven HL,Wei X,et al.Prognostic significance of pretreatment total lymphocyte count and neutrophil-to-lymphocyte ratio in extensive-stage small-cell lung cancer[J].Radiotherapy And Oncology,2018,126(3):499-505.
[9]Deng M,Ma X,Liang X,et al.Are pretreatment neutrophil-lymphocyte ratio and platelet lymphocyte ratio useful in predicting the outcomes of patients with small-cell lung cancer?[J].Oncotarget,2017,8(23):37200-37207.
[10]Dan L,Yi H,Lei L,et al.High neutrophil-to-lymphocyte ratios confer poor prognoses in patients with small cell lung cancer[J].BMC Cancer,2017(17):882.
[11]马楠,杜成,陈晓夏,等.中性粒细胞与淋巴细胞比值预测小细胞肺癌预后的价值[J].现代肿瘤医学,2018,26(14):2188-2191.
[12]Wen Q,Meng X,Xie P,et al.Evaluation of factors associated with platinum-sensitivity status and survival in limited-stage small cell lung cancer patients treated with chemoradiotherapy[J].Oncotarget,2017,8(46):81405-81418.
[13]Grieshober L,Graw S,Barnett MJ,et al.Methylation-derived Neutrophil-to-Lymphocyte Ratio and Lung Cancer Risk in Heavy Smokers[J].Cancer Prevention Research,2018,11(11):727-734.
[14]Cem M,Burak GI,Semra P,et al.Prognostic significance of neutrophil/lymphocyte ratio (NLR) and correlation with PET-CT metabolic parameters in small cell lung cancer (SCLC)[J].International Journal of Clinical Oncology,2019,24(2):168-178.
[15]Zheng YW,Wang LL,Zhao WC,et al.Risk factors for brain metastasis in patients with small cell lung cancer without prophylactic cranial irradiation[J].Strahlentherapie Und Onkologie,2018,194(12):1152-1162.
[16]罗娟,余丹,王战豪,等.中性粒细胞/淋巴细胞比值与血小板/淋巴细胞比值对肺癌和社区获得性肺炎诊断价值探讨[J].实用医院临床杂志,2018,15(5):32-35.
[17]Gang LH,Kun G,Rui J,et al.Prognostic significance of the combination of preoperative fibrinogen and the neutrophil lymphocyte ratio in patients with non small cell lung cancer following surgical resection[J].Oncology letters,2019,17(2):1435-1444.
[18]Pelin U,Burcu K,Ahmet D,et al.Immune Markers In Surgucally Early Non-small Cell Lung Cancer Pantients[J].Acta Medica Mediterranea,2019,35(1):65-69.
[19]王晓琦,王秀问.肿瘤相关中性粒细胞及外周血中性粒细胞-淋巴细胞比值与非小细胞肺癌患者预后的关系[D].山东大学,2018.
[20]Wang J,Kalhor N,Hu JH,et al.Pretreatment Neutrophilto Lymphocyte Ratio Is Associated with Poor Survival in Patients with Stage I-III Non-Small Cell Lung Cancer[J].PLoS One,2016,11(10):e0163397.
[21]Tsukioka T,Izumi N,Mizuguchi N,et al.Positive correlation between sarcopenia and elevation of neutrophil/lymphocyte ration in pathological stage IIIA (N2-positive) non-small cell lung cancer patients[J].General Thoracic and Cardiovascular Surgery,2018,66(12):716-722.
[22]Zhao L,Li T,Yang Y,et al.Clinical value of neutrophil-to-lymphocyte ratio as a predictor of prognosis of RetroNectin(R)-activated cytokine-induced killer cell therapy in advanced non-small-cell lung cancer[J].Immunotherapy,2019,11(4):273-282.
[23]吴森林,高斌.中性粒细胞/淋巴细胞比值与介入治疗中晚期非小细胞肺癌患者预后的相关性[J].医学信息,2019,32(3):82-85.
[24]Liu ZL,Zeng TT,Zhou XJ,et al.Neutrophil-lymphocyte ratio as a prognostic marker for chemotherapy in advanced lung cancer[J].International Journal of Biological Markers,2016,31(4):E395-E401.
[25]Guo D,Li MH,Chen DW,et al.Neutrophil-to-lymphocyte ratio is superior to platelet-to-lymphocyte ratio as a prognostic predictor in advanced non-small-cell lung cancer treated with first-line platinum-based chemotherapy[J].Future Oncology,2019,15(6):625-635.
[26]Doi H,Nakamatsu K,Anami S,et al.Neutrophil-to-Lymphocyte Ratio Predicts Survival After Whole-brain Radiotherapy in Non-small Cell Lung Cancer[J].In Vivo,2019,33(1):195-201.
[27]Cao DG,Xu HL,Xu XM,et al.A reliable and feasible way to predict the benefits of Nivolumab in patients with non-small cell lung cancer: a pooled analysis of 14 retrospective studies[J].Oncoimmunology,2018,7(11):e1507262.
[28]Soda H,Ogawara D,Fukuda Y,et al.Dynamics of blood neutrophil-related indices during nivolumab treatment may be associated with response to salvage chemotherapy for non-small cell lung cancer:A hypothesis-generating study[J].Thoracic Cancer,2019,10(2):341-346.
[29]Svaton M,Zemanova M,Skrickova J,et al.Chronic Inflammation as a Potential Predictive Factor of Nivolumab Therapy in Non-small Cell Lung Cancer[J].Anticancer Research,2018,38(12):6771-6782.
[30]秦垠,徐红.治疗前后中性粒细胞/淋巴细胞比值(NLR)、淋巴细胞/单核细胞比值(LMR)及血小板/淋巴细胞比值(PLR)水平变化与晚期非小细胞肺癌患者预后及化疗疗效相关性研究[D].苏州大学,2017.
[31]徐朝娜,任瑛瑛,黄晓颖,等.外周血淋巴细胞/单核细胞比值、中性粒细胞/淋巴细胞比值与EGFR突变肺癌及其转移的相关性研究[J].医学研究杂志,2018,47(7):120-125.

相似文献/References:

[1]陈学敏,彭 琼.中性粒细胞与淋巴细胞比值联合癌胚抗原对结直肠癌早期诊断的研究[J].医学信息,2019,32(02):75.[doi:10.3969/j.issn.1006-1959.2019.02.022]
 CHEN Xue-min,PENG Qiong.Early Diagnosis of Colorectal Cancer by Neutrophil-lymphocyte Ratio Combined with Carcinoembryonic Antigen[J].Journal of Medical Information,2019,32(09):75.[doi:10.3969/j.issn.1006-1959.2019.02.022]
[2]陈艳玲.内镜下止血术联合奥曲肽治疗上消化道出血的临床效果[J].医学信息,2022,35(11):141.[doi:10.3969/j.issn.1006-1959.2022.11.037]
 CHEN Yan-ling.Clinical Effect of Endoscopic Hemostasis Combined with Octreotide in the Treatment of Upper Gastrointestinal Bleeding[J].Journal of Medical Information,2022,35(09):141.[doi:10.3969/j.issn.1006-1959.2022.11.037]
[3]杨 许,吴书胜,闫 滢,等.胃癌术前外周血NLR、PLR、FIB与术后发生卵巢转移时间的相关性分析[J].医学信息,2021,34(23):39.[doi:10.3969/j.issn.1006-1959.2021.23.011]
 YANG Xu,WU Shu-sheng,YAN Ying,et al.Correlation Analysis Between Preoperative Peripheral Blood NLR,PLR,FIB and Postoperative Ovarian Metastasis Time of Gastric Cancer[J].Journal of Medical Information,2021,34(09):39.[doi:10.3969/j.issn.1006-1959.2021.23.011]
[4]张 春,王锦姝,王寿宇,等.VSD治疗骨科软组织创伤及创面感染的临床效果分析[J].医学信息,2021,34(23):47.[doi:10.3969/j.issn.1006-1959.2021.23.013]
 ZHANG Chun,WANG Jin-shu,WANG Shou-yu,et al.Clinical Effect of VSD in the Treatment of Orthopedic Soft Tissue Trauma and Wound Infection[J].Journal of Medical Information,2021,34(09):47.[doi:10.3969/j.issn.1006-1959.2021.23.013]
[5]郑 新,张 颖.慢阻肺患者PSQI评分与NLR、PLR、CRP水平及急性加重频率的相关性[J].医学信息,2020,33(12):103.[doi:10.3969/j.issn.1006-1959.2020.12.031]
 ZHENG Xin,ZHANG Ying.Correlation of PSQI Score with NLR,PLR,CRP Level and Frequency of Acute Exacerbation in COPD Patients[J].Journal of Medical Information,2020,33(09):103.[doi:10.3969/j.issn.1006-1959.2020.12.031]
[6]吴忠军,林 涛,胡 彬.兰索拉唑、奥曲肽、凝血酶三联治疗重症上消化道出血的临床疗效及并发症观察[J].医学信息,2021,34(24):64.[doi:10.3969/j.issn.1006-1959.2021.24.013]
 WU Zhong-jun,LIN Tao,HU Bin.Clinical Effects and Complications of Lansoprazole, Octreotide and Thrombin in the Treatment of Severe Upper Gastrointestinal Hemorrhage[J].Journal of Medical Information,2021,34(09):64.[doi:10.3969/j.issn.1006-1959.2021.24.013]
[7]郭 青,何前松,胡斐然,等.大黄酚通过TLR4/NF-kB信号通路途径调控小胶质细胞炎性反应[J].医学信息,2020,33(19):51.[doi:10.3969/j.issn.1006-1959.2020.19.016]
 GUO Qing,HE Qian-song,HU Fei-ran,et al.Chrysophanol Regulates Microglial Inflammatory Response Through TLR4/NF-kB Signaling Pathway[J].Journal of Medical Information,2020,33(09):51.[doi:10.3969/j.issn.1006-1959.2020.19.016]
[8]师园园.ST段抬高型心肌梗死患者术前NLR与冠脉病变程度的关系[J].医学信息,2021,34(01):91.[doi:10.3969/j.issn.1006-1959.2021.01.024]
 SHI Yuan-yuan.The Relationship Between Preoperative NLR and Coronary Artery Lesions in Patients with ST-segment Elevation Myocardial Infarction[J].Journal of Medical Information,2021,34(09):91.[doi:10.3969/j.issn.1006-1959.2021.01.024]
[9]马 岚,方 珉.中性粒细胞/淋巴细胞比值预测前循环急性大血管闭塞性缺血性卒中血管内治疗的预后价值[J].医学信息,2022,35(24):102.[doi:10.3969/j.issn.1006-1959.2022.24.019]
 MA Lan,FANG Min.Prognostic Value of Neutrophil/lymphocyte Ratio in Predicting Endovascular Treatment of Anterior Circulation Acute Large Vessel Occlusive Ischemic Stroke[J].Journal of Medical Information,2022,35(09):102.[doi:10.3969/j.issn.1006-1959.2022.24.019]
[10]杨传振.斜疝巨大疝囊TAPP中不同疝囊处理策略的应用研究[J].医学信息,2021,34(08):98.[doi:10.3969/j.issn.1006-1959.2021.08.025]
 YANG Chuan-zhen.Application Study of Different Hernia Sac Management Strategies in Indirect Hernia Giant Hernia Sac TAPP[J].Journal of Medical Information,2021,34(09):98.[doi:10.3969/j.issn.1006-1959.2021.08.025]

更新日期/Last Update: 2019-05-01